Steven G. Charapata

Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS

Peter S. Staats, Thomas Yearwood, Steven G. Charapata et al. · JAMA · 2004 · 644 citations

Nursing, Pharmacology, Pharmacotherapy +17

A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain

Richard Rauck, Mark S. Wallace, Michael S. Leong et al. · Journal of Pain and Symptom Management · 2006 · 302 citations · Full text

Nursing, Pharmacotherapy, Pain Management +12

Intrathecal Ziconotide in the Treatment of Chronic Nonmalignant Pain: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Mark S. Wallace, Steven G. Charapata, Robert B. Fisher et al. · Neuromodulation Technology at the Neural Interface · 2006 · 203 citations

Nursing, Pharmacotherapy, Pain Management +12

Intrathecal Ziconotide for Severe Chronic Pain: Safety and Tolerability Results of an Open-Label, Long-Term Trial

Mark S. Wallace, Richard Rauck, Robert B. Fisher et al. · Anesthesia & Analgesia · 2008 · 108 citations

Medicine, Pharmacology, Pharmacotherapy +17

Open-Label, Multicenter Study of Combined Intrathecal Morphine and Ziconotide: Addition of Morphine in Patients Receiving Ziconotide for Severe Chronic Pain

Lynn R. Webster, Keri L. Fakata, Steven G. Charapata et al. · Pain Medicine · 2007 · 74 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17